Buscar resultados de ensayos clínicos
Leukemia, T-cell, Chronic - 25 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) Condición: Adult T-cell Leukemia-Lymphoma Fecha: 2012-06-19 Intervenciones:
|
Completed |
Nombre del estudio: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma Condición: Acute T-Cell Leukemia-Lymphoma Fecha: 2003-05-20 Intervenciones: Biological: Alemtuzumab Infusion of Campath-1H 3 mg on day # 1, 10 mg on day #2, and 30 mg day # 3 follo |
Active, not recruiting |
Nombre del estudio: Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia Condición: Adult T-Cell Leukemia (ATL) Fecha: 2009-06-17 Intervenciones:
|
Completed |
Nombre del estudio: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma Condición: Adult T-cell Leukemia-lymphoma Fecha: 2009-06-09 Intervenciones: Biological: KW-0761 KW-0761 is administered weekly for 8 weeks as an intravenous infusion of 2 hours at |
Completed |
Nombre del estudio: Lenalidomide in HTLV-1 Adult T-Cell Leukemia Condición: Adult T Cell Leukemia/Lymphoma Fecha: 2011-01-10 Intervenciones: Drug: Lenalidomide 25mg or 10mg (based on creatinine clearance) once daily for days 1-21 of a 28 day cyc |
Active, not recruiting |
Nombre del estudio: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma Condición: Adult T-Cell Leukemia-Lymphoma Fecha: 2012-11-07 Intervenciones: Drug: Lenalidomide 25 mg of Lenalidomide administered orally once daily |
Recruiting |
Nombre del estudio: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma Condición:
Fecha: 2016-04-10 Intervenciones:
|
Completed |
Nombre del estudio: A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma Condición:
Fecha: 2010-07-22 Intervenciones: Drug: Lenalidomide Lenalidomide: 25mg daily on day 1-21 of each 28days cycle (1st cohort), 25 mg daily o |
Completed |
Nombre del estudio: A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) Condición:
Fecha: 2005-09-01 Intervenciones:
|
Completed |
Nombre del estudio: A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Condición:
Fecha: 2011-05-12 Intervenciones:
|